Efficacy of deferoxamine on paraquat poisoning.
10.4046/trd.2007.62.2.113
- Author:
Jin Won HUH
1
;
Yangjin JEGAL
;
Sang Bum HONG
;
Yeon Mok OH
;
Tae Sun SHIM
;
Chae Man LIM
;
Sang Do LEE
;
Woo Sung KIM
;
Dong Soon KIM
;
Won Dong KIM
;
Younsuck KOH
Author Information
1. Department of Internal Medicine Inje University, Korea.
- Publication Type:Original Article
- Keywords:
Paraquat;
Deferoxamine;
Mortality
- MeSH:
Deferoxamine*;
Eating;
Fibrosis;
Humans;
Incidence;
Infusions, Intravenous;
Intensive Care Units;
Iron;
Lung;
Lung Injury;
Mortality;
Paraquat*;
Poisoning*;
Respiratory Insufficiency
- From:Tuberculosis and Respiratory Diseases
2007;62(2):113-118
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Paraquat is known to induce oxidant injury that results in multiorgan failure and lung fibrosis. Iron has been considered to play a key role in paraquat-induced oxidant lung injury. This study examined the effect of deferoxamine, an iron-chelating agent, in the treatment of paraquat poisoning. METHODS: From September, 2001 to April, 2005, 28 patients with paraquat poisoning who were admitted at a medical intensive care unit of a University-affiliated hospital, were enrolled in this study. Sixteen patients were treated according to the paraquat poisoning treatment guidelines and 12 received an intravenous infusion of deferoxamine in addition to the treatment guidelines. RESULTS: There were no differences between the two groups in terms of age, gender, severity of paraquat poisoning, and the time elapsed from ingestion to presentation at hospital. There was no difference in overall mortality between the two groups but the incidence of respiratory failure in the deferoxamine group was higher than in the conventional group(4/7 versus 0/9, p=0.019). CONCLUSIONS: Deferoxamine seems to have no clinical benefit compared with the conventional treatment.
